CGM metrics predict risk for stage 3 type 1 diabetes better than patient characteristics
Continuous glucose monitoring (CGM) metrics can predict imminent stage 3 type 1…
Kaiser’s Risant Health to add Cone Health
Kaiser Permanente announced the acquisition of Cone Health in North Carolina, expanding…
Growth factors linked to stem cell aging in bone marrow study
A study conducted at the Jackson Laboratory focused on hematopoietic stem cells…
New study warns of potential pandemic risk from α-H1N2 swine flu virus
A recent study in Nature Communications focused on circulating swine influenza viruses,…
Fixed-Ratio Insulin Combinations May Reduce Side Effects
Using fixed-ratio insulin combinations (FRC) can reduce side effects in treating diabetes,…
Roche Adds Another Neuro Alliance, Inking R&D Pact With RNA-Editing Startup Ascidian
Roche has partnered with Ascidian Therapeutics, a startup focused on editing RNA…
Annexon previews emerging data on ANX007 for geographic atrophy
Lori Taylor of Annexon Biosciences presented data on ANX007 for the treatment…
With type 2 diabetes, ‘we’re failing right now,’ FDA chief says
FDA Commissioner Robert Califf highlighted the concerning trend of deteriorating health outcomes…
Six tips for staying safe
Extreme heat poses risks for people spending time outdoors, such as runners,…
Nutritious diet may protect against type 2 diabetes, regardless of genetics
A study from the University of Eastern Finland shows that adhering to…